Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Caparrelli

Thoracic Surgery (Cardiothoracic Vascular Surgery) Manchester, NH Medical Doctor

NPI 1750434890 CMS profile 34152

100 McGregor St Ste B600a, Manchester, NH 03102

Open in the dashboard

General payments

$203,539

321 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$7,590 paid to institutions, not to them · program years 2023–2025

Through program year 2025, David Caparrelli of Manchester, NH is reported in the CMS Open Payments database as having received $203,539 across 321 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $7,590 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $62,534 73
2024 General $42,278 55
2023 General $47,520 83
2022 General $23,005 39
2021 General $20,693 42
2020 General $4,729 7
2019 General $2,780 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Caparrelli
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to David Caparrelli were reported at $62,534. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year David Caparrelli Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $2,780 $886 $178–$3,167 $163
2020 $4,729 $341 $108–$1,605 $114
2021 $20,693 $453 $125–$1,886 $132
2022 $23,005 $695 $180–$2,566 $149
2023 $47,520 $745 $205–$2,662 $160
2024 $42,278 $799 $214–$2,967 $164
2025 $62,534 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $153,597 157 payments
  2. Medtronic, Inc. $17,719 54 payments
  3. Zimmer Biomet Holdings, Inc. $12,197 15 payments
  4. Baxter Healthcare $12,026 8 payments
  5. Edwards Lifesciences Corporation $2,415 18 payments
  6. Inari Medical, Inc. $1,279 7 payments
  7. W. L. Gore & Associates, Inc. $850 9 payments
  8. Medtronic Vascular, Inc. $718 6 payments
  9. Abbott Laboratories $700 15 payments
  10. Silk Road Medical, Inc. $526 5 payments
  11. Other $1,513 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $159,450 78 payments
  2. Travel and Lodging $23,387 62 payments
  3. Food and Beverage $11,071 176 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,630 5 payments
Products named General payments · program years 2019–2025
  1. AtriCure cryoICE cryoSPHERE Cryoablation System $61,969 68 payments
  2. SYNERGY ABLATION SYSTEM $57,931 50 payments
  3. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $31,761 25 payments
  4. ACTIFUSE $11,438 4 payments
  5. ThoreconRigid Fixation $10,188 4 payments
  6. ENDURANT IIS $8,620 26 payments
  7. ALTAPORE $7,530 1 payment
  8. ARTISS $7,530 1 payment
  9. CELSTAT $7,530 1 payment
  10. ADEPT $7,530 1 payment
  11. Other $50,257 195 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$111,410

Medicare's payments for the services billed

Medicare patients

227

Average age 77

Services billed

376

92 women, 135 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 67%
Arthritis 46%
Heart failure 38%
Atrial fibrillation 38%
Diabetes 34%
Chronic kidney disease 32%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

321 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record